Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.
Manufactured by
Guangzhou Wondfo Biotech Co., Ltd.
Guangzhou, Guangdong, China
Guangzhou Wondfo Biotech Co., Ltd. founded in 1992 and headquartered in Guangzhou science city. Wondfo focuses on the R D, manufacturing, sales and service of IVD industry , providing professional rapid diagnosis and chronic disease management solutions. Wondfo has 9 technology platforms . Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumors, etc . We provide services to over 150 countries and regions . In 2015, Wondfo was listed on the Shenzhen Stock Exchange, becoming the first public company in POCT in China .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
Shenzhen YHLO Biotech Co., Ltd.
China · 4 relevant products
Xenta Biomedical Science Co.,Ltd
China · 2 relevant products
31 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 45 closest product alternatives
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
Shenzhen YHLO Biotech Co., Ltd. · China
An indirect immunofluorescence technology platform for serological testing and antibody detection. The system is utilized for diagnosis of autoimmune and infectious diseases through fluorescence-based immunoassay methodology.
Xenta Biomedical Science Co.,Ltd · China
An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.
42 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products